Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-07

Clinical Trial Update: Long-term Safety Study of the GORE® HELEX® Septal Occluder [NA]

View source ↗

Summary

Long-term safety study results for the GORE HELEX Septal Occluder have been posted after completion of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GORE HELEX Septal Occluder (GORE HELEX Septal Occluder)

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Septal Defect, Atrial | NA | Status: COMPLETED | Results posted: 2012-02-07